521 related articles for article (PubMed ID: 32200332)
1. Discovery of thiazole-based-chalcones and 4-hetarylthiazoles as potent anticancer agents: Synthesis, docking study and anticancer activity.
Farghaly TA; Masaret GS; Muhammad ZA; Harras MF
Bioorg Chem; 2020 May; 98():103761. PubMed ID: 32200332
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and biological evaluation of 4-amino-5-cinnamoylthiazoles as chalcone-like anticancer agents.
Ayati A; Esmaeili R; Moghimi S; Oghabi Bakhshaiesh T; Eslami-S Z; Majidzadeh-A K; Safavi M; Emami S; Foroumadi A
Eur J Med Chem; 2018 Feb; 145():404-412. PubMed ID: 29335206
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, Cytotoxicity Evaluation, Molecular Docking and Utility of Novel Chalcones as Precursors for Heterocycles Incorporating Pyrazole Moiety.
Gomha SM; Abdallah MA; Abbas IM; Kazem MSH
Med Chem; 2018; 14(4):344-355. PubMed ID: 29065841
[TBL] [Abstract][Full Text] [Related]
4. Novel benzotriazole N-acylarylhydrazone hybrids: Design, synthesis, anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis and FAK inhibition.
Kassab AE; Hassan RA
Bioorg Chem; 2018 Oct; 80():531-544. PubMed ID: 30014921
[TBL] [Abstract][Full Text] [Related]
5. Design, Synthesis, and Molecular Docking of Paracyclophanyl-Thiazole Hybrids as Novel CDK1 Inhibitors and Apoptosis Inducing Anti-Melanoma Agents.
Aly AA; Bräse S; Hassan AA; Mohamed NK; El-Haleem LEA; Nieger M; Morsy NM; Alshammari MB; Ibrahim MAA; Abdelhafez EMN
Molecules; 2020 Nov; 25(23):. PubMed ID: 33260954
[TBL] [Abstract][Full Text] [Related]
6. Molecular Docking Study, Cytotoxicity, Cell Cycle Arrest and Apoptotic Induction of Novel Chalcones Incorporating Thiadiazolyl Isoquinoline in Cervical Cancer.
Tantawy MA; Sroor FM; Mohamed MF; El-Naggar ME; Saleh FM; Hassaneen HM; Abdelhamid IA
Anticancer Agents Med Chem; 2020; 20(1):70-83. PubMed ID: 31696811
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and
Alimujiang Y; Maimaiti A; Ablise M; Yang Z; Liu Z; Wang Y; Mutalipu Z; Yan T
Anticancer Agents Med Chem; 2024; 24(6):423-435. PubMed ID: 38204258
[TBL] [Abstract][Full Text] [Related]
8. Design, synthesis and QSAR study of 2'-hydroxy-4'-alkoxy chalcone derivatives that exert cytotoxic activity by the mitochondrial apoptotic pathway.
Marquina S; Maldonado-Santiago M; Sánchez-Carranza JN; Antúnez-Mojica M; González-Maya L; Razo-Hernández RS; Alvarez L
Bioorg Med Chem; 2019 Jan; 27(1):43-54. PubMed ID: 30482548
[TBL] [Abstract][Full Text] [Related]
9. Cytotoxicity, molecular modeling, cell cycle arrest, and apoptotic induction induced by novel tetrahydro-[1,2,4]triazolo[3,4-a]isoquinoline chalcones.
Mohamed MF; Hassaneen HM; Abdelhamid IA
Eur J Med Chem; 2018 Jan; 143():532-541. PubMed ID: 29207336
[TBL] [Abstract][Full Text] [Related]
10. Novel p-Functionalized Chromen-4-on-3-yl Chalcones Bearing Astonishing Boronic Acid Moiety as MDM2 Inhibitor: Synthesis, Cytotoxic Evaluation and Simulation Studies.
Bhatia RK; Singh L; Garg R; Kaur M; Yadav M; Madan J; Kancherla S; Pissurlenkar RRS; Coutinho EC
Med Chem; 2020; 16(2):212-228. PubMed ID: 31146672
[TBL] [Abstract][Full Text] [Related]
11. Novel ciprofloxacin hybrids using biology oriented drug synthesis (BIODS) approach: Anticancer activity, effects on cell cycle profile, caspase-3 mediated apoptosis, topoisomerase II inhibition, and antibacterial activity.
Kassab AE; Gedawy EM
Eur J Med Chem; 2018 Apr; 150():403-418. PubMed ID: 29547830
[TBL] [Abstract][Full Text] [Related]
12. Synthesis, anticancer effect and molecular modeling of new thiazolylpyrazolyl coumarin derivatives targeting VEGFR-2 kinase and inducing cell cycle arrest and apoptosis.
Mohamed TK; Batran RZ; Elseginy SA; Ali MM; Mahmoud AE
Bioorg Chem; 2019 Apr; 85():253-273. PubMed ID: 30641320
[TBL] [Abstract][Full Text] [Related]
13. Synthesis, biological evaluation, and molecular modelling of new naphthalene-chalcone derivatives as potential anticancer agents on MCF-7 breast cancer cells by targeting tubulin colchicine binding site.
Wang G; Liu W; Gong Z; Huang Y; Li Y; Peng Z
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):139-144. PubMed ID: 31724435
[TBL] [Abstract][Full Text] [Related]
14. Design, synthesis and biological evaluation of a new series of thiazolyl-pyrazolines as dual EGFR and HER2 inhibitors.
Sever B; Altıntop MD; Radwan MO; Özdemir A; Otsuka M; Fujita M; Ciftci HI
Eur J Med Chem; 2019 Nov; 182():111648. PubMed ID: 31493743
[TBL] [Abstract][Full Text] [Related]
15. Design and synthesis of imidazo[2,1-b]thiazole-chalcone conjugates: microtubule-destabilizing agents.
Kamal A; Balakrishna M; Nayak VL; Shaik TB; Faazil S; Nimbarte VD
ChemMedChem; 2014 Dec; 9(12):2766-80. PubMed ID: 25313981
[TBL] [Abstract][Full Text] [Related]
16. Eco-friendly sequential one-pot synthesis, molecular docking, and anticancer evaluation of arylidene-hydrazinyl-thiazole derivatives as CDK2 inhibitors.
El-Naggar AM; El-Hashash MA; Elkaeed EB
Bioorg Chem; 2021 Mar; 108():104615. PubMed ID: 33484942
[TBL] [Abstract][Full Text] [Related]
17. Design and Synthesis of Aspirin-chalcone Mimic Conjugates as Potential Anticancer Agents.
Mohamed-Ezzat RA; Srour AM
Anticancer Agents Med Chem; 2024; 24(7):544-557. PubMed ID: 38204260
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and evaluation of novel isoxazolyl chalcones as potential anticancer agents.
Wan M; Xu L; Hua L; Li A; Li S; Lu W; Pang Y; Cao C; Liu X; Jiao P
Bioorg Chem; 2014 Jun; 54():38-43. PubMed ID: 24747188
[TBL] [Abstract][Full Text] [Related]
19. Thiazole-Chalcone Hybrids as Prospective Antitubercular and Antiproliferative Agents: Design, Synthesis, Biological, Molecular Docking Studies and In Silico ADME Evaluation.
Kasetti AB; Singhvi I; Nagasuri R; Bhandare RR; Shaik AB
Molecules; 2021 May; 26(10):. PubMed ID: 34064806
[TBL] [Abstract][Full Text] [Related]
20. Novel 2-(5-Aryl-4,5-Dihydropyrazol-1-yl)thiazol-4-One as EGFR Inhibitors: Synthesis, Biological Assessment and Molecular Docking Insights.
Al-Warhi T; El Kerdawy AM; Said MA; Albohy A; Elsayed ZM; Aljaeed N; Elkaeed EB; Eldehna WM; Abdel-Aziz HA; Abdelmoaz MA
Drug Des Devel Ther; 2022; 16():1457-1471. PubMed ID: 35607598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]